Bionet (1784) — Cash Flow Quality Index
Bionet (1784) has a Cash Flow Quality Index of 1.94x as of December 2025. Operating cash flow of NT$28.46 Million exceeds net income of NT$14.71 Million, indicating high earnings quality where cash backs reported profits. Explore 1784 cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Bionet Cash Flow Quality Index (2018–2025)
Historical Cash Flow Quality Index for Bionet across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check cash flow reinvestment rate of Bionet to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Bionet (2018–2025)
Year-by-year earnings quality comparison for Bionet. For live market cap and the full company financial profile, see how much is Bionet worth.
| Year | Quality Index | Operating CF (TWD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.88x | NT$148.04 Million | NT$51.43 Million | ▲ +36.5% |
| 2024 | 2.11x | NT$176.49 Million | NT$83.70 Million | ▲ +47.5% |
| 2023 | 1.43x | NT$153.09 Million | NT$107.08 Million | ▼ -42.6% |
| 2022 | 2.49x | NT$94.65 Million | NT$37.97 Million | ▲ +639.8% |
| 2021 | 0.34x | NT$13.88 Million | NT$41.19 Million | ▼ -97.1% |
| 2020 | 11.47x | NT$73.66 Million | NT$6.42 Million | ▲ +2823.6% |
| 2019 | 0.39x | NT$2.67 Million | NT$6.80 Million | ▲ +173.3% |
| 2018 | -0.54x | NT$-12.97 Million | NT$24.23 Million | — |